From April 1, 2024 to June 30, 2024, the company has repurchased 3,203,800 shares, representing 1.72% for CNY 27.39 million. With this, the company has completed the repurchase of 7,203,800 shares, representing 3.81% for CNY 63.36 million under the buyback announced on October 30, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7.78 CNY | -0.38% |
|
-0.51% | -34.46% |
1st Jan change | Capi. | |
---|---|---|
-34.46% | 200M | |
+61.53% | 848B | |
+33.66% | 627B | |
-3.66% | 363B | |
+15.06% | 318B | |
+9.18% | 299B | |
+11.45% | 234B | |
+15.18% | 225B | |
+15.67% | 179B | |
+2.47% | 167B |
- Stock Market
- Equities
- 002826 Stock
- News Tibet AIM Pharm. Inc.
- Tranche Update on Tibet AIM Pharm. Inc.'s Equity Buyback Plan announced on October 30, 2023.